Jia Jie Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	253.59	296.47	112.94	354.42	125.53	172.28
Short-Term Investments	164.06	104.06	62.06	29.74	128.21	114.03
Trading Asset Securities	86	81.03	88.05	-	-	-
Cash & Short-Term Investments	503.65	481.56	263.05	384.17	253.75	286.31
Cash Growth	-19.93%	83.07%	-31.53%	51.40%	-11.37%	-16.81%
Accounts Receivable	43.8	49.5	48.06	17.77	16.21	21.06
Other Receivables	2.1	1.83	1.85	2.82	2.78	3.38
Receivables	45.91	51.33	49.91	20.59	18.98	24.43
Inventory	33.56	27.68	24.49	24.68	26.64	20.8
Prepaid Expenses	10.1	10.8	7.98	4.99	17.23	8.65
Other Current Assets	3.2	3.12	2.91	2.89	0.61	0.1
Total Current Assets	596.42	574.48	348.34	437.31	317.21	340.28
Property, Plant & Equipment	491.38	491.8	450.75	448.81	451.21	444.91
Long-Term Investments	609.94	598.43	493.13	402.86	112.83	112.63
Goodwill	-	71.86	71.86	19.78	19.78	19.78
Other Intangible Assets	74	2.31	3.69	0.4	0.46	0.5
Long-Term Accounts Receivable	4.95	5.15	5.4	6.72	7.4	2.16
Long-Term Deferred Tax Assets	49.93	50.92	46.95	49.94	47.45	48.48
Other Long-Term Assets	95.75	93.94	62.18	47.11	47.62	52.66
Total Assets	1,922	1,889	1,482	1,413	1,004	1,021
Accounts Payable	20.17	24.46	12.46	11.27	10.3	11.72
Accrued Expenses	-	59.04	72.18	67.9	47.99	53.54
Short-Term Debt	-	50	-	237.45	-	-
Current Portion of Leases	2.17	2.43	2.46	0.81	2.53	2.29
Current Income Taxes Payable	7.17	6.61	5.28	1.57	0.38	0.91
Current Unearned Revenue	0.36	0.82	0.38	0.53	0.36	0.85
Other Current Liabilities	116.23	27.48	24.1	17.31	11.97	12.63
Total Current Liabilities	146.1	170.84	116.85	336.84	73.52	81.93
Long-Term Debt	74.08	3.61	4.03	4.7	5.18	1.51
Long-Term Leases	0.71	0.24	1.99	0.94	1.09	2.82
Other Long-Term Liabilities	-	0.21	0.21	0.21	0.21	0.21
Total Liabilities	220.89	174.89	123.08	342.69	80	86.47
Common Stock	1,187	1,187	987.37	889.37	889.37	889.37
Additional Paid-In Capital	249.37	251.58	91.05	58.3	57.01	57.01
Retained Earnings	335.38	340.72	349.83	163.02	18.87	24.28
Comprehensive Income & Other	-100.97	-95.86	-97.23	-63.82	-67.27	-62.79
Total Common Equity	1,671	1,684	1,331	1,047	897.98	907.87
Minority Interest	30.34	30.19	28.19	23.35	25.99	27.05
Shareholders' Equity	1,701	1,714	1,359	1,070	923.96	934.92
Total Liabilities & Equity	1,922	1,889	1,482	1,413	1,004	1,021
Total Debt	76.97	56.27	8.48	243.9	8.8	6.61
Net Cash (Debt)	426.68	425.29	254.57	140.26	244.95	279.69
Net Cash Growth	-31.32%	67.06%	81.49%	-42.74%	-12.42%	-17.73%
Net Cash Per Share	3.59	3.65	2.59	1.57	2.75	3.14
Filing Date Shares Outstanding	118.74	118.74	98.74	88.94	88.94	88.94
Total Common Shares Outstanding	118.74	118.74	98.74	88.94	88.94	88.94
Working Capital	450.33	403.64	231.49	100.47	243.7	258.36
Book Value Per Share	14.07	14.18	13.48	11.77	10.10	10.21
Tangible Book Value	1,597	1,610	1,255	1,027	877.74	887.59
Tangible Book Value Per Share	13.45	13.56	12.72	11.54	9.87	9.98
Land	-	178.91	178.91	178.91	178.55	171.76
Buildings	-	400.52	380.85	382.81	380.89	376.79
Machinery	-	127.86	92.92	78.21	92.18	86.21